FindTrial
Sign In

Personalized lifestyle prescription (Exercise and Diet) for Indians with Cardio metabolic Diseases

Development and Validation of a Novel, Third-Generation Lifestyle (Exercise and Nutrition) Prescription for Precision Medicine in Indians with cardio metabolic diseases (DEVELOP Study). - DEVELOP Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100028
Enrollment
2250
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers and Cardio Metabolic patients (stages 0-4) (table 1) (2), aged 18-60 years, sedentary to moderately active (PAL 2) 34, willing to adapt to exercise and provide informed consent.

Exclusion criteria

Exclusion criteria: Contraindications to structured exercise (e.g., uncontrolled hypertension, unstable angina), inability to exercise due to conditions like osteoarthritis, or non-compliance risks (e.g., distant residence, cognitive impairment)

Design outcomes

Primary

MeasureTime frame
Development and validation of a third- generation precision lifestyle prescription (TGPLP) in improving adherence to optimal physical activity and diet compared to standard of careTimepoint: Baseline and 12 weeks—

Secondary

MeasureTime frame
Cost-effectiveness, acceptability, and scalability of third generation precision lifestyle prescription for a larger randomized controlled trial.Timepoint: 24- 36 months—

Countries

India

Contacts

Public ContactDr Pranathi Racha

St. Johns Research Institute

denis.xavier@stjohns.in9886126801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026